subject: Pharmaxis Ltd. (pxs) - Financial And Strategic Analysis Review - Aarkstore Enterprise [print this page] Aarkstore announce a new report "Pharmaxis Ltd. (PXS) - Financial and Strategic Analysis Review " through its vast collection of market research report.
Pharmaxis Ltd. (Pharmaxis) is a publicly held Australian-based pharmaceutical company. The company is principally engaged in the development of new products for the diagnosis and treatment of chronic respiratory and immune disorders. The product portfolio of the company includes, aridol designed to identify twitchy or hyper-responsive airways and to assist in diagnosing and managing asthma and bronchitol intended to restore normal lung hydration, improve lung function and to help relieve the mucus burden in the lungs of patients suffering from chronic respiratory conditions.
Pharmaxis Ltd. Key Recent Developments
Apr 14, 2010: Pharmaxis Completes Phase 3 Trial Of Bronchitol
Feb 09, 2010: Pharmaxis Completes Phase I PXS25 Trial
Feb 09, 2010: Pharmaxis Completes Acquisition Of Topigen
Oct 14, 2009: Pharmaxis Q1 Fiscal 2009 Net Loss Increases
Jul 22, 2009: Pharmaxis Q4 Fiscal 2009 Net Loss Increases
This comprehensive SWOT profile of Pharmaxis Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pharmaxis Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
